Tarius SAC Tracker®

 

Background Analysis: US FDA Joint Advisory Committee to Review Avedro’s VibeX/KXL System to Treat Rare Corneal Disorder Following LASIK – FEB 24, 2015 (DODAC)

The SAC Tracker report for this meeting is only available for SAC Tracker Premium subscribers.

The SAC Tracker reports are available for FREE on this site until 10 days after the meeting is held. 

To obtain unlimited access to SAC Tracker meeting reports back to 2010 and onwards, including the committee members' voting history, you must subscribe to the SAC Tracker Premium service.

Read more and subscribe here.


METADATA: Sponsor: Avedro Drug Name: riboflavin ophthalmic solutions with UV-A irradiation Drug Class: ophthalmic solution Indication: keratoconus or corneal ectasia